The Edo State Government has confirmed 15 fatalities resulting from a Lassa fever outbreak that began in December 2024. The announcement comes as the state intensifies its efforts to curb the spread of the disease.
Dr. Stephenson Ojeifo, Director of Public Health at the Edo State Ministry of Health, addressed public concerns on Tuesday, revealing that the government is actively responding to the outbreak.
“As of today, Edo State has recorded over 1,000 suspected cases of Lassa fever. Out of these, 103 have tested positive,” Dr. Ojeifo stated. “From the 103 confirmed cases, we have recorded 15 deaths, while others have been treated and discharged.”
According to Dr. Ojeifo, Governor Monday Okpebholo has prioritized strengthening surveillance and contact tracing measures, ensuring the availability of necessary resources to manage the situation effectively. The government’s strategy focuses on identifying and isolating cases to prevent further transmission.
However, Dr. Ojeifo highlighted a critical challenge contributing to the high mortality rate: late referrals. “The problem is that patients are only referred to ISTH [Irrua Specialist Teaching Hospital] when their condition has deteriorated,” he explained.
“We have been sensitizing residents to seek medical attention if they experience persistent fever that does not resolve, so that samples can be tested and treatment can commence early if needed.”
The Director of Public Health strongly urged healthcare providers to promptly refer suspected cases to designated treatment centers. He issued a stern warning against unauthorized treatment of Lassa fever cases, stating that any hospital found violating this directive would face stringent sanctions. This measure aims to ensure that patients receive appropriate care in facilities equipped and authorized to handle the complexities of Lassa fever.
Beyond Lassa fever, Dr. Ojeifo also reported on the state’s efforts to manage Mpox cases. “We have recorded 11 suspected cases of Mpox, with five confirmed positives,” he said. Reassuringly, he added that no deaths have been recorded in connection with Mpox, attributing this success to timely medical intervention for all affected individuals.
